Lipocine PE Ratio 2012-2020 | LPCN

Current and historical p/e ratio for Lipocine (LPCN) from 2012 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lipocine PE ratio as of July 13, 2020 is 0.00.
Lipocine PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-07-13 1.25 0.00
2020-03-31 0.48 $-0.50 0.00
2019-12-31 0.38 $-0.50 0.00
2019-09-30 2.81 $-0.55 0.00
2019-06-30 1.95 $-0.55 0.00
2019-03-31 2.31 $-0.56 0.00
2018-12-31 1.30 $-0.55 0.00
2018-09-30 1.38 $-0.65 0.00
2018-06-30 1.30 $-0.75 0.00
2018-03-31 1.53 $-0.91 0.00
2017-12-31 3.44 $-1.04 0.00
2017-09-30 3.97 $-0.95 0.00
2017-06-30 4.02 $-0.91 0.00
2017-03-31 3.90 $-0.92 0.00
2016-12-31 3.68 $-1.04 0.00
2016-09-30 4.46 $-1.13 0.00
2016-06-30 3.04 $-1.30 0.00
2016-03-31 10.15 $-1.24 0.00
2015-12-31 12.93 $-1.09 0.00
2015-09-30 11.83 $-1.16 0.00
2015-06-30 8.58 $-1.13 0.00
2015-03-31 6.90 $-1.42 0.00
2014-12-31 5.26 $-1.60 0.00
2014-09-30 6.11 $-1.28 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.060B $0.000B
Lipocine, Inc. is a specialty pharmaceutical company. It develops pharmaceutical products for use in men's and women's health. The Company's lead product candidate, LPCN 1021, is in Phase 3 and is targeted to treat symptoms of low testosterone for men in need of testosterone replacement therapy. Its additional pipeline candidates include LPCN 1111, a next generation oral testosterone therapy product, and LPCN 1107, indicated for the prevention of preterm birth and is currently in Phase 1. Lipocine Inc. is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.689B 37.28
Takeda Pharmaceutical (TAK) Japan $53.912B 9.45
Astellas Pharma (ALPMY) Japan $29.844B 15.12
UCB SA (UCBJF) Belgium $23.924B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Merck (MKGAF) Germany $16.013B 21.00
Grifols, S.A (GRFS) Spain $12.830B 15.95
Catalent (CTLT) United States $12.000B 46.39
Neurocrine Biosciences (NBIX) United States $11.708B 54.11
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.504B 45.22
IPSEN SA ADR (IPSEY) France $7.733B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.842B 9.35
United Therapeutics (UTHR) United States $5.103B 9.67
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.695B 512.56
Nektar Therapeutics (NKTR) United States $4.158B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.793B 13.95
FibroGen (FGEN) United States $3.668B 0.00
ChemoCentryx (CCXI) United States $3.499B 0.00
PTC Therapeutics (PTCT) United States $3.457B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.517B 10.34
Pacira BioSciences (PCRX) United States $2.341B 47.91
Cronos Group (CRON) Canada $2.187B 62.70
Sage Therapeutics (SAGE) United States $2.135B 0.00
Corcept Therapeutics (CORT) United States $1.813B 17.98
Xencor (XNCR) United States $1.783B 0.00
USANA Health Sciences (USNA) United States $1.765B 18.11
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.658B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.599B 12.23
Akebia Therapeutics (AKBA) United States $1.541B 0.00
Indivior (INVVY) United States $1.488B 18.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.470B 15.84
Zogenix (ZGNX) United States $1.466B 0.00
Heron Therapeutics (HRTX) United States $1.418B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.338B 0.00
Esperion Therapeutics (ESPR) United States $1.314B 0.00
Karyopharm Therapeutics (KPTI) United States $1.302B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.104B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.001B 44.66
Tilray (TLRY) Canada $0.933B 0.00
VAXART, INC (VXRT) United States $0.899B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.873B 0.00
Endo (ENDP) Ireland $0.781B 1.21
ImmunoGen (IMGN) United States $0.736B 0.00
Aerie Pharmaceuticals (AERI) United States $0.622B 0.00
Radius Health (RDUS) United States $0.617B 0.00
Collegium Pharmaceutical (COLL) United States $0.563B 0.00
Trillium Therapeutics (TRIL) Canada $0.557B 0.00
Molecular Templates (MTEM) United States $0.555B 0.00
Ardelyx (ARDX) United States $0.550B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.519B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.490B 11.85
Crinetics Pharmaceuticals (CRNX) United States $0.479B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.463B 18.06
Siga Technologies (SIGA) United States $0.455B 0.00
Flexion Therapeutics (FLXN) United States $0.454B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
DURECT (DRRX) United States $0.394B 0.00
Ocular Therapeutix (OCUL) United States $0.392B 0.00
Harpoon Therapeutics (HARP) United States $0.389B 0.00
Altimmune (ALT) United States $0.388B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.368B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Calithera Biosciences (CALA) United States $0.355B 0.00
Organogenesis Holdings (ORGO) United States $0.354B 0.00
MEI Pharma (MEIP) United States $0.348B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.292B 0.00
Concert Pharmaceuticals (CNCE) United States $0.292B 0.00
PROFOUND MEDICL (PROF) Canada $0.271B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.237B 0.00
Redhill Biopharma (RDHL) Israel $0.224B 0.00
CASI Pharmaceuticals (CASI) United States $0.221B 0.00
Lannett Co Inc (LCI) United States $0.211B 4.64
KalVista Pharmaceuticals (KALV) United States $0.205B 0.00
Rafael Holdings (RFL) United States $0.197B 0.00
OptiNose (OPTN) United States $0.194B 0.00
Nature's Sunshine Products (NATR) United States $0.186B 24.46
IMV INC (IMV) Canada $0.185B 0.00
Jounce Therapeutics (JNCE) United States $0.173B 4.13
Nivalis Therapeutics (ALPN) United States $0.173B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Aquestive Therapeutics (AQST) United States $0.141B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.121B 0.00
Otonomy (OTIC) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.110B 0.00
Heat Biologics (HTBX) United States $0.108B 0.00
MediWound (MDWD) Israel $0.105B 0.00
Xeris Pharmaceuticals (XERS) United States $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.101B 0.00
Onconova Therapeutics (ONTX) United States $0.098B 0.00
Recro Pharma (REPH) United States $0.096B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.095B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.094B 0.00
CTI BioPharma (CTIC) United States $0.093B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.082B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.081B 0.00
ElectroCore (ECOR) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
CV Sciences (CVSI) United States $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
PolarityTE (PTE) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 29.09
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
IsoRay (ISR) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Novan (NOVN) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
GTx (ONCT) United States $0.037B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.034B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Shineco (TYHT) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 32.14
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00